Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial

Alexey V. Danilov; Hongli Li; Oliver W. Press; Ilan Shapira; Lode J. Swinnen; Ariela Noy; Erin Reid; Sonali M. Smith; Jonathan W. Friedberg

doi:10.1080/10428194.2016.1201573

Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial

Alexey V. Danilov, Hongli Li, Oliver W. Press, Ilan Shapira, Lode J. Swinnen, Ariela Noy, Erin Reid, Sonali M. Smith, Jonathan W. Friedberg

Knight Cancer Institute

Research output: Contribution to journal › Letter › peer-review

20 Scopus citations

Original language	English (US)
Pages (from-to)	461-465
Number of pages	5
Journal	Leukemia and Lymphoma
Volume	58
Issue number	2
DOIs	https://doi.org/10.1080/10428194.2016.1201573
State	Published - Feb 1 2017

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2016.1201573

Cite this

Danilov, A. V., Li, H., Press, O. W., Shapira, I., Swinnen, L. J., Noy, A., Reid, E., Smith, S. M., & Friedberg, J. W. (2017). Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leukemia and Lymphoma, 58(2), 461-465. https://doi.org/10.1080/10428194.2016.1201573

Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. / Danilov, Alexey V.; Li, Hongli; Press, Oliver W. et al.
In: Leukemia and Lymphoma, Vol. 58, No. 2, 01.02.2017, p. 461-465.

Research output: Contribution to journal › Letter › peer-review

Danilov, AV, Li, H, Press, OW, Shapira, I, Swinnen, LJ, Noy, A, Reid, E, Smith, SM & Friedberg, JW 2017, 'Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial', Leukemia and Lymphoma, vol. 58, no. 2, pp. 461-465. https://doi.org/10.1080/10428194.2016.1201573

@article{8039db50358c4d719f88e90a41ce6ae8,

title = "Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial",

author = "Danilov, {Alexey V.} and Hongli Li and Press, {Oliver W.} and Ilan Shapira and Swinnen, {Lode J.} and Ariela Noy and Erin Reid and Smith, {Sonali M.} and Friedberg, {Jonathan W.}",

year = "2017",

month = feb,

day = "1",

doi = "10.1080/10428194.2016.1201573",

language = "English (US)",

volume = "58",

pages = "461--465",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "2",

}

TY - JOUR

T1 - Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL)

T2 - a sub-analysis of SWOG S0816 Phase 2 trial

AU - Danilov, Alexey V.

AU - Li, Hongli

AU - Press, Oliver W.

AU - Shapira, Ilan

AU - Swinnen, Lode J.

AU - Noy, Ariela

AU - Reid, Erin

AU - Smith, Sonali M.

AU - Friedberg, Jonathan W.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=84978952276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978952276&partnerID=8YFLogxK

U2 - 10.1080/10428194.2016.1201573

DO - 10.1080/10428194.2016.1201573

M3 - Letter

C2 - 27386786

AN - SCOPUS:84978952276

SN - 1042-8194

VL - 58

SP - 461

EP - 465

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this